Long-term costs of introducing HPV-DNA post-treatment surveillance to national cervical cancer screening in Ireland.

Abstract

INTRODUCTION Co-testing (cytology plus human papillomavirus DNA testing) as part of cervical cancer surveillance in Ireland increases one-time testing costs. Of interest to policy makers was the long-term impact of these costs accompanied by decreases in intensity of recalls for women with no detected abnormalities. METHODS A cost analysis of cytology… (More)
DOI: 10.1586/14737167.2015.1057126

5 Figures and Tables

Topics

  • Presentations referencing similar topics